SCHEMBL250885

SCHEMBL250885

O=C(O)N(Cc1ccccc1)C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CES1 P23141 5/20 0.53
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CYP2C19 P33261 1/20 0.47
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46
FAAH O00519 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 3/20 0.44
ALDH1A1 P00352 1/20 0.44
RIPK1 Q13546 2/20 0.43
CPA1 P15085 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24193442 0.88 MEN1 (0.47) CES1MEN1KMT2AHTTL3MBTL1
SCHEMBL6648152 0.86 MEN1 (0.50) CES1MEN1KMT2AHTTL3MBTL1
SCHEMBL10338250 0.86 MEN1 (0.46) CES1MEN1KMT2AHTTL3MBTL1
SCHEMBL5007989 0.83 MEN1 (0.44) CES1MEN1KMT2AHTTL3MBTL1
SCHEMBL1877690 0.83 KMT2A (0.51) MEN1KMT2AHTTL3MBTL1CYP2C19
SCHEMBL4678735 0.82 FDPS (0.38) CES1MEN1KMT2AHTTL3MBTL1
SCHEMBL5007991 0.82 MTOR (0.47) CES1MEN1KMT2AHTTL3MBTL1
SCHEMBL7502743 0.81 KMT2A (0.56) MEN1KMT2AHTTL3MBTL1CYP2C19
SCHEMBL24666646 0.79 SMN1; SMN2 (0.47) CES1MEN1KMT2AHTTL3MBTL1
SCHEMBL45807 0.79 KMT2A (0.47) MEN1KMT2ACYP2C19RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368544-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII H. Hoffnabb-La Roche Ag (CH) 2018-09-05 EP disclosed
WO-2017072062-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII F. HOFFMANN-LA ROCHE AG (CH) 2017-05-04 WO disclosed
EP-3080103-A1 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY Biogen MA Inc. (US) 2016-10-19 EP disclosed
WO-2015089337-A1 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY BIOGEN IDEC MA INC. (US) 2015-06-18 WO disclosed
EP-2401275-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS Respiratorius AB (SE) 2012-01-04 EP disclosed
WO-2010097410-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2010-09-02 WO disclosed
EP-1737811-A4 CETP INHIBITORS MERCK & CO INC (US) 2009-06-17 EP disclosed
EP-1737811-A1 CETP INHIBITORS Merck & Co., Inc. (US) 2007-01-03 EP disclosed
US-6967196-B1 Sulfonamide compounds and uses thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2005-11-22 US disclosed
WO-2005100298-A1 CETP INHIBITORS MERCK & CO., INC. (US) 2005-10-27 WO disclosed